This website uses cookies to ensure you get the best experience on our website.
If you continue to use this site we will assume that you are okay with it.
For further information please visit our privacy policy page.
I agree

Key services

Services

ImmunoQure is focused on developing multiple pre-IND programs in parallel and entering into partnerships with pharmaceutical companies for the further clinical development of these products.

IQ001

A cytokine that has been validated in the innate immune system and that is a key regulator of human autoimmune diseases. Antibody panels have been generated, characterized and in vitro mechanism of action studies have been completed.

IQ002

A cytokine that has been validated in the innate immune system and that is a key regulator of human autoimmune diseases. Antibody panels have been generated, characterized. In vitro mechanism of action and in vivo efficacy studies have been completed.

IQ003

A cytokine that has been validated as a key regulator of discrete cytokine networks that have been validated clinically and commercially in multiple human autoimmune diseases. Antibody panels have been generated and characterized.

Science

ImmunoQure AG is focusing on the research and development of human antibodies for the treatment of inflammatory and autoimmune diseases.

Through our unique access to special patient populations, we are able to identify patients that harbor antibodies against key proteins that are involved in preventing many common human diseases.

Our technology platform allows us to rescue desirable antibodies from these patients and generate novel drug candidates with exceptional speed.

ImmunoQure maintains collaborations with leading academic centers in Europe that include specialized clinical institutions, translational medicine and research centers of excellence, and provide us with the ability to access the most relevant patient populations and disease model systems.